YTHDF1 and central nervous system cancer: METTL3, METTL14, WTAP, RBM15, RBM15B, YTHDC2, YTHDF1, YTHDF2, YTHDF3, HNRNPA2B1 and HNRNPC levels were upregulated in gliomas, while ZC3H13 and FTO levels were downregulated [33].